glp-1 and hypertension Model of blood pressure lowering with GLP-1R activation. GLP-1 receptor agonists (GLP-1RAs): cardiovascular

Nissen observes, because studies of these drugs for obesity show that they reduce death due to various other causes. After median treatment of 47.4 months, the six-component cardiorenal end point occurred in 23.7% of tirzepatide-treated patients versus 27.4% of dulaglutide-treated patients, translating to a hazard ratio (HR) of 0.84 (95% CI, 0.79-0.90

Mide asidi sekresyonunu tevik edebilir, mide suyundaki hidrojen iyonlarnn konsantrasyonunu artrabilir, mide mukozasnn bariyer fonksiyonunu glendirebilir ve mide lserlerinin oluumunu nleyebilir

Fibroblasts as sentinel cells

How Exercise Prevents Depression References Haroon E et al

Psychopharmacology (2025)

In a 68-week study, participants taking semaglutide lost an average of 14.9% of their body weight, while those on a placebo lost just 2.4%